In Vitro and In Vivo Experimental Studies of PM_2.5 on Disease Progression

Area of Science:

• Environmental Health
• Toxicology
• Epidemiology

Background:

• Air pollution, specifically fine particulate matter (PM2.5), poses a global health risk, especially in developing nations.
• PM2.5 is a complex mixture with diverse sources and components, contributing to various chronic diseases.
• While epidemiological studies link PM2.5 to respiratory, cardiovascular, and metabolic diseases, precise mechanisms require further investigation.

Purpose of the Study:

• To review in vitro and in vivo experimental studies on PM2.5's role in disease progression over the past decade.
• To elucidate the pathogenic mechanisms underlying PM2.5-induced chronic diseases.
• To provide clear insights into how PM2.5 contributes to disease development.

Main Methods:

• Literature review of experimental studies (in vitro and in vivo).
• Focus on research published within the last 10 years.
• Analysis of studies investigating PM2.5's effects on disease pathways.

Main Results:

• PM2.5 exposure is associated with increased oxidative stress, inflammation, and genotoxicity.
• Experimental evidence supports PM2.5's contribution to respiratory, cardiovascular, and diabetic conditions.
• Mechanisms include cellular damage and disruption of physiological processes.

Conclusions:

• Experimental studies confirm PM2.5's detrimental effects on health.
• Oxidative stress, inflammation, and genotoxicity are key mechanisms in PM2.5-induced disease.
• Further research is needed to fully understand and mitigate the health impacts of PM2.5.